Showing results (721-730 of 802) with videos related to
Sort By:
Pageof 81
American Journal of Hematology|March 5, 2024
SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasmsGarima Pandey, Lucia Mazzacurati, Tegan M Rowsell, et al.JAACAP Open|January 19, 2024
Neurodevelopmental profiles of 4-year-olds in the Navajo Birth Cohort StudyBrandon J Rennie, Somer L Bishop, Bennett L Leventhal, et al.Journal of Geriatric Oncology|July 17, 2021
Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatmentMostafa R Mohamed, Kaitlin Kyi, Supriya G Mohile, et al.Blood|May 2, 2013
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemiaEric Padron, Jeffrey S Painter, Sateesh Kunigal, et al.Blood|September 16, 2008
Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signalingP K Epling-Burnette, Lubomir Sokol, Xianhong Chen, et al.Journal of Medicinal Chemistry|November 28, 2006
Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivativesChristopher McGuigan, Alshaimaa Hassan-Abdallah, Sheila Srinivasan, et al.The British Journal of Dermatology|November 16, 2018
Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulationS S Hampras, M Tommasino, Y Zhao, et al.Journal of the Air & Waste Management Association (1995)|January 7, 2022
Combustion of C1 and C2 PFAS: Kinetic modeling and experimentsJonathan D Krug, Paul M Lemieux, Chun-Wai Lee, et al.Leukemia Research|March 6, 2012
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium studySusan Bell Nyland, Daniel J Krissinger, Michael J Clemente, et al.The American Journal of Cardiology|March 11, 1999
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trialW S Weintraub, S D Culler, A Kosinski, et al.Pageof 81